NCT02744547View on ClinicalTrials.gov

Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Beta Thalassemia Major
Interventions
DIETARY_SUPPLEMENT

Spirulina

Spirulina in a dose of 250 mg/kg/day will be given orally for 3 months.

Trial Locations (1)

0000

Faculty of Medicine- Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT02744547 - Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C | Biotech Hunter | Biotech Hunter